Tofogliflozin, a novel and selective SGLT2 inhibitor improves glycemic control and lowers body weight in patients with type 2 diabetes mellitus inadequately. Reference standards of Tofogliflozin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Tofogliflozin-d5
Catalogue No.:PA STI 083570
CAS :
Molecular Formula : C22H21D5O6
Molecular Weight : 391.47
Tofogliflozin
Catalogue No.:PA 20 4050000
Molecular Formula : C22H26O6
Molecular Weight : 386.44
(2-Bromo-4-(4-ethylbenzyl)phenyl)methanol
Catalogue No.:PA 20 4051000
Molecular Formula : C16H17BrO
Molecular Weight : 305.22
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
